dc.contributor.author | Aval, SF | |
dc.contributor.author | Lotfi, H | |
dc.contributor.author | Sheervalilou, R | |
dc.contributor.author | Zarghami, N | |
dc.date.accessioned | 2018-08-26T09:43:48Z | |
dc.date.available | 2018-08-26T09:43:48Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/58631 | |
dc.description.abstract | Two distinguishing characteristics of stem cells, their continuous division in the undifferentiated state and growth into any cell types, are orchestrated by a number of cell signaling pathways. These pathways act as a niche factor in controlling variety of stem cells. The core stem cell signaling pathways include Wingless-type (Wnt), Hedgehog (HH), and Notch. Additionally, they critically regulate the self-renewal and survival of cancer stem cells. Conversely, stem cells' main properties, lineage commitment and stemness, are tightly controlled by epigenetic mechanisms such as DNA methylation, histone modifications and non-coding RNA-mediated regulatory events. MicroRNAs (miRNAs) are cellular switches that modulate stem cells outcomes in response to diverse extracellular signals. Numerous scientific evidences implicating miRNAs in major signal transduction pathways highlight new crosstalks of cellular processes. Aberrant signaling pathways and miRNAs levels result in developmental defects and diverse human pathologies. This review discusses the crosstalk between the components of main signaling networks and the miRNA machinery, which plays a role in the context of stem cells development and provides a set of examples to illustrate the extensive relevance of potential novel therapeutic targets. | |
dc.language.iso | English | |
dc.relation.ispartof | Biomedicine and Pharmacotherapy | |
dc.subject | bone morphogenetic protein | |
dc.subject | bone sialoprotein | |
dc.subject | cyclin D1 | |
dc.subject | microRNA | |
dc.subject | microRNA 1 | |
dc.subject | microRNA 132 | |
dc.subject | microRNA 133b | |
dc.subject | microRNA 141 | |
dc.subject | microRNA 155 | |
dc.subject | microRNA 20 | |
dc.subject | microRNA 200 | |
dc.subject | microRNA 21 | |
dc.subject | microRNA 210 | |
dc.subject | microRNA 34a | |
dc.subject | microRNA 34b | |
dc.subject | microRNA 34c | |
dc.subject | microRNA 375 | |
dc.subject | microRNA 708 | |
dc.subject | Notch receptor | |
dc.subject | Notch1 receptor | |
dc.subject | Notch2 receptor | |
dc.subject | Notch3 receptor | |
dc.subject | Smad2 protein | |
dc.subject | Smad3 protein | |
dc.subject | sonic hedgehog protein | |
dc.subject | transcription factor RUNX2 | |
dc.subject | transforming growth factor beta | |
dc.subject | unclassified drug | |
dc.subject | unindexed drug | |
dc.subject | untranslated RNA | |
dc.subject | Wnt protein | |
dc.subject | microRNA | |
dc.subject | 3' untranslated region | |
dc.subject | acute liver failure | |
dc.subject | adipogenesis | |
dc.subject | bone development | |
dc.subject | cancer stem cell | |
dc.subject | cell invasion | |
dc.subject | cell lineage | |
dc.subject | cell migration | |
dc.subject | cell survival | |
dc.subject | chronic liver disease | |
dc.subject | Crigler Najjar syndrome type I | |
dc.subject | DNA methylation | |
dc.subject | down regulation | |
dc.subject | epigenetics | |
dc.subject | familial hypercholesterolemia | |
dc.subject | gene overexpression | |
dc.subject | heart infarction | |
dc.subject | hepatitis C | |
dc.subject | hereditary liver disease | |
dc.subject | histone modification | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | induced pluripotent stem cell | |
dc.subject | liver cell carcinoma | |
dc.subject | liver disease | |
dc.subject | metastasis | |
dc.subject | neural stem cell | |
dc.subject | osteoblast | |
dc.subject | priority journal | |
dc.subject | regenerative medicine | |
dc.subject | Review | |
dc.subject | signal transduction | |
dc.subject | smooth muscle cell | |
dc.subject | stem cell self-renewal | |
dc.subject | stem cell transplantation | |
dc.subject | urea cycle disorder | |
dc.subject | Wnt signaling pathway | |
dc.subject | animal | |
dc.subject | biological model | |
dc.subject | cytology | |
dc.subject | metabolism | |
dc.subject | signal transduction | |
dc.subject | stem cell | |
dc.subject | Animals | |
dc.subject | Cell Lineage | |
dc.subject | Humans | |
dc.subject | MicroRNAs | |
dc.subject | Models, Biological | |
dc.subject | Signal Transduction | |
dc.subject | Stem Cells | |
dc.title | Tuning of major signaling networks (TGF-?, Wnt, Notch and Hedgehog) by miRNAs in human stem cells commitment to different lineages: Possible clinical application | |
dc.type | Article | |
dc.citation.volume | 91 | |
dc.citation.spage | 849 | |
dc.citation.epage | 860 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1016/j.biopha.2017.05.020 | |